SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-126998
Filing Date
2016-06-14
Accepted
2016-06-14 08:00:54
Documents
16
Period of Report
2016-06-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-13231_18k.htm 8-K 22085
2 EX-99.1 a16-13231_1ex99d1.htm EX-99.1 22039
3 GRAPHIC g132311mmi001.gif GRAPHIC 31834
4 GRAPHIC g132311mmi002.gif GRAPHIC 127875
5 GRAPHIC g132311mmi003.gif GRAPHIC 98275
6 GRAPHIC g132311mmi004.gif GRAPHIC 92070
7 GRAPHIC g132311mmi005.gif GRAPHIC 79177
8 GRAPHIC g132311mmi006.gif GRAPHIC 121559
9 GRAPHIC g132311mmi007.gif GRAPHIC 86966
10 GRAPHIC g132311mmi008.gif GRAPHIC 105043
11 GRAPHIC g132311mmi009.gif GRAPHIC 90130
12 GRAPHIC g132311mmi010.gif GRAPHIC 74773
13 GRAPHIC g132311mmi011.gif GRAPHIC 75242
14 GRAPHIC g132311mmi012.gif GRAPHIC 83451
15 GRAPHIC g132311mmi013.gif GRAPHIC 94976
16 GRAPHIC g132311mmi014.gif GRAPHIC 99067
  Complete submission text file 0001104659-16-126998.txt   1783056
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 161712071
SIC: 2834 Pharmaceutical Preparations